ArticlePoultry science2026
Exogenous adiponectin attenuates lipid accumulation and is associated with enhanced TG and VLDL secretion in primary chicken hepatocytes.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adiponectin (ADPN) is an adipocyte-derived peptide that exerts a pivotal regulatory role in lipid metabolism in mammals. However, its functional role in avian lipid metabolism needs to be further explored, particularly in the liver, the central organ governing metabolic homeostasis in poultry. In this study, the effects of exogenous recombinant adiponectin on lipid metabolism processes were examined in primary chicken hepatocytes. Regardless of palmitic acid pretreatment, adiponectin significantly attenuated intracellular lipid accumulation. Mechanistically, adiponectin was accompanied by increased adiponectin receptor 2 (ADPNR2) mRNA expression and stimulated the efflux of triglycerides (TG) and very low-density lipoproteins (VLDL) from hepatocytes. These effects were accompanied by short-term activation of the AMP-activated protein kinase (AMPK) signaling pathway. Meanwhile, adiponectin enhanced the cellular uptake of glucose and fatty acids and upregulated the expression of genes related to fatty acid synthesis. It also suppressed the expression of genes involved in fatty acid oxidation, suggesting a cell-intrinsic negative feedback mechanism. In conclusion, the results indicate that enhanced lipid efflux may be an important mechanism contributing to the adiponectin-mediated reduction of hepatic lipid accumulation. These findings provide further evidence for the involvement of adiponectin in the regulation of avian hepatic lipid metabolism and suggest that adiponectin and its receptor pathways may represent potential targets for future studies aimed at improving liver health and productivity in poultry.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.